TheraRadar
Data updated: May 26, 2026

GRANISETRON HYDROCHLORIDE

Oncology Approved 2007-12-31

GRANISETRON HYDROCHLORIDE is indicated for the treatment of Nausea; Vomiting.

Source: FDA Label • Fresenius Kabi
24
Indications
--
Phase 3 Trials
18
Years on Market

GRANISETRON HYDROCHLORIDE Approval History

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
187 FDA actions from 2007 to 2025
Mar 2025 SUPPL
Label · Labeling
Mar 2025 ORIGINAL
Update
Oct 2023 SUPPL
Label · Labeling

What GRANISETRON HYDROCHLORIDE Treats

2 indications

GRANISETRON HYDROCHLORIDE is approved for 2 conditions since its original approval in 2007. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Nausea
  • Vomiting
Source: FDA Label

GRANISETRON HYDROCHLORIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to GRANISETRON HYDROCHLORIDE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

AKYNZEO
NETUPITANT
2 shared
HELSINN HLTHCARE
Shared indications:
ANTIVERT
MECLIZINE HYDROCHLORIDE
2 shared
CASPER PHARMA LLC
Shared indications:
APREPITANT
APREPITANT
2 shared
Viatris
Shared indications:
📋

Clinical Trial Registry

1 trials
Trial Sponsor ID Phase Status Title
NCT03924518 GRANTISS 2018-ZZJHZX-009 Ph 2 completed Adjunctive Granisetron Therapy in Patients With Sepsis or Septic Shock
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

GRANISETRON HYDROCHLORIDE FDA Label Details

Indications & Usage

FDA Label (PDF)

GRANISETRON HYDROCHLORIDE is indicated for the treatment of Nausea; Vomiting.

Looking for the branded version?

GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE

Full clinical data, patents, trials, and competitive landscape for granisetron hydrochloride.

See GRANISETRON HYDROCHLORIDE PRESERVATIVE FREE

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.